Profil bibliographique

Lv X

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

21Publications signalées

15Citations signalées

2Affiliations récentes

Les institutions déclarées

Yuhuangding Hospital Ophthalmology Associates (United States)

Les domaines associés

Cancer Immunotherapy and BiomarkersExtracellular vesicles in diseaseNanoplatforms for cancer theranosticsImmune cells in cancerMetastasis and carcinoma case studies

Les publications récentes

Accès ouvert 2026 article OpenAlex

Engineering Extracellular Vesicles for Tumor Targeted Therapy: Source Optimization, Modification, and Clinical Application

Sui J, Qin H, Zhang Z, Lv X et autres

cn, us (code pays fourni par la source)

0 citations DOAJ (DOAJ: Directory of Open Access Journals)

Accès ouvert 2025 article OpenAlex

Exploring the Potential Value of Lactylation and Macrophage Polarization-Related Genes as Biomarkers for TNF-α Inhibitor Response in Inflammatory Bowel Disease

Han L, Lin G, Lv X, Li S et autres

us (code pays fourni par la source)

0 citations DOAJ (DOAJ: Directory of Open Access Journals)

Accès ouvert 2021 article OpenAlex

Metabolomics Study of Isocaloric Different Dietary Patterns on the Life Span in Healthy Population

Chang-peng Zhang, Qingyi Zhu, Jianjun Liu, Yingjie Dong et autres

0 citations DOAJ (DOAJ: Directory of Open Access Journals)

Accès ouvert 2021 article OpenAlex

Prognostic Significance of Uric Acid in Patients with Obstructive and Nonobstructive Coronary Artery Disease Undergoing D-SPECT

Shan Xu, Liu L, Guoqiang Yin, Mohammed AQ et autres

0 citations DOAJ (DOAJ: Directory of Open Access Journals)

Accès ouvert 2020 article OpenAlex

Expression and Importance of TMED2 in Multiple Myeloma Cells

Ge X, Y Jiang, Lv X, Liu X

1 citation DOAJ (DOAJ: Directory of Open Access Journals)

Accès ouvert 2020 article OpenAlex

Enhancement of Pancreatic Cancer Therapy Efficacy by Type-1 Matrix Metalloproteinase-Functionalized Nanoparticles for the Selective Delivery of Gemcitabine and Erlotinib

Na Yin, Huanhuan Yu, X Zhang, Lv X

0 citations DOAJ (DOAJ: Directory of Open Access Journals)

Accès ouvert 2020 article OpenAlex

Application of Intravenous Lidocaine in Obese Patients Undergoing Painless Colonoscopy: A Prospective, Randomized, Double-Blind, Controlled Study

Li X, Lv X, Zhujun Jiang, Nie X et autres

9 citations DOAJ (DOAJ: Directory of Open Access Journals)

Accès ouvert 2020 article OpenAlex

Tumor-Associated CD163+ M2 Macrophage Infiltration is Highly Associated with PD-L1 Expression in Cervical Cancer

Zhe Cheng, Haoran Wu, Bin Xu, Lv X et autres

0 citations DOAJ (DOAJ: Directory of Open Access Journals)

Accès ouvert 2020 article OpenAlex

Detection of PD-L1 Expression and Its Clinical Significance in Circulating Tumor Cells from Patients with Non-Small-Cell Lung Cancer

Yufan Cheng, Tianyu Wang, Lv X, Ren‐Ke Li et autres

1 citation DOAJ (DOAJ: Directory of Open Access Journals)

Accès ouvert 2020 article OpenAlex

GRHL2 Acts as an Anti-Oncogene in Bladder Cancer by Regulating ZEB1 in Epithelial-Mesenchymal Transition (EMT) Process

Juan Shen, Lv X, Li Zhang

0 citations DOAJ (DOAJ: Directory of Open Access Journals)

Accès ouvert 2020 article OpenAlex

miR-346 Inhibited Apoptosis Against Myocardial Ischemia-Reperfusion Injury via Targeting Bax in Rats

Lv X, Peng Lu, Hu Y, Tao Xu

0 citations DOAJ (DOAJ: Directory of Open Access Journals)

Accès ouvert 2019 article OpenAlex

Aberrant Expression of miR-592 Is Associated with Prognosis and Progression of Renal Cell Carcinoma

Lv X, Jun Shen, Zijian Guo, Lianbao Kong et autres

0 citations DOAJ (DOAJ: Directory of Open Access Journals)

Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.